The overall strength of Jinling Pharmaceutical Co., Ltd.

The company has invested heavily in the construction of Nanjing Jinling Pharmaceutical Factory, Hefei Limin Pharmaceutical Factory, Fuzhou meifeng Pharmaceutical Factory and Zhejiang Tianfeng Pharmaceutical Factory, all of which have passed the national GMP certification. The factory has the ability to produce and process more than 200 varieties of solid preparations, small injections, large infusions, oral liquids, sponges, eye drops, creams, liniments and Chinese and western medicines. At the same time, a modern Chinese herbal medicine extraction production line with an annual processing capacity of nearly 10,000 tons has been established. Nanjing Jinling Pharmaceutical Factory, with an investment of 240 million yuan, is a national demonstration base for modern production of traditional Chinese medicine.

Relying on two major commercial companies-Nanjing Huadong Pharmaceutical Co., Ltd. and Nanjing Yitong Pharmaceutical Co., Ltd., the company has established a relatively complete market network throughout the country. The two major commercial companies have passed the national GSP certification, and have offices in major cities and regions across the country, and subordinate 30 Jinling large pharmacies.

The company has enterprise postdoctoral research center and national pilot base of traditional Chinese medicine injection. The company's technology center has a research laboratory with advanced equipment and a joint laboratory for the research of new Chinese medicine jointly established with Shanghai University of Traditional Chinese Medicine. More than 40% of the scientific researchers have graduate degrees, and more than 15% have senior titles. At present, there are more than 20 varieties under study. Among them, Mailuoning secondary development research project has been included in the "Tenth Five-Year Plan" major project of the Ministry of Science and Technology.

The company has established five modern GAP planting bases in Yunnan, Zhejiang, Henan and other places, aiming at popularizing the standardized green planting project of Chinese herbal medicines and using advanced tissue culture methods and seedling raising techniques to achieve the GAP goal of Chinese herbal medicine planting.

The company's health food production base-Jinling Pharmaceutical Nanjing Jinwei Health Products Branch. It mainly produces freeze-dried powder, capsules, spirulina capsules and oral liquid of resurrected royal jelly.

The company's main products and varieties are: Mailuoning series products, Celeron, Shuangxiang Paishi Granules, Sulifei, Weidean, lentinan, Sibaiyan Ointment, Jinluoning, Manyanning, Gelatin Sponge, etc. 160 products and varieties, among which Mailuoning injection, Weidean tablets and Lentinus edodes injection are national traditional Chinese medicine protection varieties. Mailuoning injection is an exclusive Chinese medicine preparation with independent intellectual property rights, and it is the leading product of the company, which has the unique effect of preventing and treating cardiovascular and cerebrovascular diseases.